Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
Clinical trial NCT02317549 · TERMINATED
Trial details
- NCT number
- NCT02317549
- Sponsor
- Leading BioSciences, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-03-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.